Target intelligence / Profile preview

Manganese-binding lipoprotein MntC (MntC) (MntC)

Target
MntC
Molecular classification
Transporter, Lipoprotein, Solute-binding protein, ABC transporter component
01

Overview

Manganese-binding lipoprotein MntC is a critical cell-surface component of the MntABC ATP-binding cassette (ABC) transporter system in Staphylococcus aureus (UniProt P0A0H3). It functions as a high-affinity solute-binding protein that captures essential manganese (Mn2+) ions from the host environment, even under conditions of extreme metal limitation imposed by host nutritional immunity (PubMed: 25691600). Manganese is a vital cofactor for bacterial enzymes such as superoxide dismutase, which are necessary for neutralizing reactive oxygen species and surviving the host's oxidative burst during infection (PubMed: 15150225). Due to its high conservation across clinical isolates and its accessibility on the bacterial surface, MntC has been a primary target for multi-antigen vaccine development, such as the SA4Ag candidate (PubMed: 28457771). While small-molecule inhibitors are less common, targeting MntC aims to starve the pathogen of essential nutrients or provide a handle for immune-mediated clearance (PubMed: 24595231). The protein's structure, characterized by a cluster of four alpha-helices surrounding a metal-binding site, makes it a highly specific and stable target for therapeutic intervention (PDB 4XU1).

Other names
Manganese-binding protein MntCMntCABC transporter manganese-binding proteinSA0596SitA-like proteinStaphylococcus aureus manganese transporter C
02

Mechanism of action

MntC serves as a vaccine antigen to induce neutralizing antibodies that facilitate opsonophagocytic killing of Staphylococcus aureus and potentially block manganese acquisition, thereby impairing bacterial defense against oxidative stress (PubMed: 25691600, PubMed: 28457771).

03

Biological functions

Manganese transportMetal ion homeostasisOxidative stress resistanceVirulence factor
04

Disease associations

InfectionStaphylococcal infectionBacteremiaSepsis
05

Safety considerations

Lack of clinical efficacy in Phase 3 trials for surgical site infections (PubMed: 30835318)Potential for immune evasion through alternative metal transport systems like MntH (PubMed: 15150225)
06

Interacting drugs

SA4Ag (Staphylococcus aureus 4-antigen vaccine)

1 more in the full profile.

07

Biomarkers

Anti-MntC IgG antibody levels (PubMed: 28457771)

Beyond the preview

Go deeper on Manganese-binding lipoprotein MntC (MntC) (MntC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Manganese-binding lipoprotein MntC (MntC) (MntC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call